Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-Bromobenzyl bromide is an organic compound that is a white to yellow solid. It is used as an intermediate in the synthesis of various organic compounds.

823-78-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 823-78-9 Structure
  • Basic information

    1. Product Name: 3-Bromobenzyl bromide
    2. Synonyms: ALPHA,3-DIBROMOTOLUENE;ALPHA,M-DIBROMOTOLUENE;3-BROMOBENZYL BROMIDE;3-Brombenzyl bromide;3-Bromo Benzyl Bromide m-Bromobenzyl Bromide;3-BromobenzylBromide98%;3-Bromobenzylbromide,99%;m-Bromobenzyl
    3. CAS NO:823-78-9
    4. Molecular Formula: C7H6Br2
    5. Molecular Weight: 249.93
    6. EINECS: 212-519-1
    7. Product Categories: Aromatic Halides (substituted);Benzyl;alkyl bromide
    8. Mol File: 823-78-9.mol
  • Chemical Properties

    1. Melting Point: 39-41 °C(lit.)
    2. Boiling Point: 130 °C12 mm Hg
    3. Flash Point: >230 °F
    4. Appearance: White/Adhering Crystals or Crystalline Powder
    5. Density: 1,56 g/cm3
    6. Vapor Pressure: 0.0224mmHg at 25°C
    7. Refractive Index: 1.6066 (estimate)
    8. Storage Temp.: 2-8°C
    9. Solubility: Chloroform (Sparingly), Methanol (Slightly)
    10. Water Solubility: Insoluble in water.
    11. BRN: 2078683
    12. CAS DataBase Reference: 3-Bromobenzyl bromide(CAS DataBase Reference)
    13. NIST Chemistry Reference: 3-Bromobenzyl bromide(823-78-9)
    14. EPA Substance Registry System: 3-Bromobenzyl bromide(823-78-9)
  • Safety Data

    1. Hazard Codes: C
    2. Statements: 34-37
    3. Safety Statements: 26-36/37/39-45-25
    4. RIDADR: UN 3261 8/PG 2
    5. WGK Germany: 3
    6. RTECS:
    7. F: 19
    8. TSCA: Yes
    9. HazardClass: 8
    10. PackingGroup: III
    11. Hazardous Substances Data: 823-78-9(Hazardous Substances Data)

823-78-9 Usage

Uses

Used in Pharmaceutical Industry:
3-Bromobenzyl bromide is used as a synthetic intermediate for the production of 1,7-di(3-bromobenzyl)cyclen and substituted 8-arylquinoline, which are phosphodiesterase 4 (PDE4) inhibitors. These inhibitors have potential applications in the treatment of various diseases, such as inflammatory and autoimmune disorders.
Used in Organic Synthesis:
3-Bromobenzyl bromide is used as a starting material in the synthesis of various organic compounds. It can undergo reduction with diethylzinc in the presence of Pd(PPh3)4 to yield the corresponding hydrocarbon. This property makes it a versatile building block in organic chemistry for the preparation of a wide range of compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 823-78-9 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 8,2 and 3 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 823-78:
(5*8)+(4*2)+(3*3)+(2*7)+(1*8)=79
79 % 10 = 9
So 823-78-9 is a valid CAS Registry Number.
InChI:InChI=1/C7H6Br2/c8-5-6-2-1-3-7(9)4-6/h1-4H,5H2

823-78-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A15075)  3-Bromobenzyl bromide, 99%   

  • 823-78-9

  • 10g

  • 300.0CNY

  • Detail
  • Alfa Aesar

  • (A15075)  3-Bromobenzyl bromide, 99%   

  • 823-78-9

  • 50g

  • 936.0CNY

  • Detail
  • Alfa Aesar

  • (A15075)  3-Bromobenzyl bromide, 99%   

  • 823-78-9

  • 250g

  • 3861.0CNY

  • Detail

823-78-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Bromobenzyl bromide

1.2 Other means of identification

Product number -
Other names 3-BrPhCH2Br

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:823-78-9 SDS

823-78-9Relevant articles and documents

Synthesis, inhibition properties against xanthine oxidase and molecular docking studies of dimethyl N-benzyl-1H-1,2,3-triazole-4,5-dicarboxylate and (N-benzyl-1H-1,2,3-triazole-4,5-diyl)dimethanol derivatives

Yagiz, Güler,Noma, Samir Abbas Ali,Altundas, Aliye,Al-khafaji, Khattab,Taskin-Tok, Tugba,Ates, Burhan

, (2021/01/28)

This study focused on synthesis various dimethyl N-benzyl-1H-1,2,3-triazole-4,5-dicarboxylate and (N-benzyl-1H-1,2,3-triazole-4,5-diyl)dimethanol derivatives under the conditions of green chemistry without the use of solvent and catalysts. Their inhibition properties were also investigated on xanthine oxidase (XO) activity. All dimethanol and dicarboxylate derivatives exhibited significant inhibition activities with IC50 values ranging from 0.71 to 2.25 μM. Especially, (1-(3-bromobenzyl)-1H-1,2,3-triazole-4,5-diyl)dimethanol (5c) and dimethyl 1-(4-chlorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxylate (6 g) compounds were found to be the most promising derivatives on the XO enzyme inhibition with IC50 values 0.71 and 0.73 μM, respectively. Moreover, the double docking procedure was to evaluate compound modes of inhibition and their interactions with the protein (XO) at atomic level. Surprisingly, the docking results showed a good correlation with IC50 [correlation coefficient (R2 = 0.7455)]. Also, the docking results exhibited that the 5c, 6f and 6 g have lowest docking scores ?4.790, ?4.755, and ?4.730, respectively. These data were in agreement with the IC50 values. These results give promising beginning stages to assist in the improvement of novel and powerful inhibitor against XO.

THERAPEUTIC COMPOUNDS AND METHODS TO TREAT INFECTION

-

Paragraph 0422-0423, (2019/02/13)

Disclosed herein are compounds of formula I: or a salt thereof and compositions comprising a compound of formula I or a pharmaceutically acceptable salt thereof. Also disclosed herein are methods for treating or preventing a bacterial infection in an animal comprising administering to the animal a compound of formula I or a pharmaceutically acceptable salt thereof, alone or in combination with a bacterial efflux pump inhibitor.

Design, synthesis and biological evaluation of low molecular weight CXCR4 ligands

Sakyiamah, Maxwell M.,Kobayakawa, Takuya,Fujino, Masayuki,Konno, Makoto,Narumi, Tetsuo,Tanaka, Tomohiro,Nomura, Wataru,Yamamoto, Naoki,Murakami, Tsutomu,Tamamura, Hirokazu

supporting information, p. 1130 - 1138 (2019/02/16)

The chemokine receptor CXCR4/stromal cell-derived factor-1 (SDF-1: CXCL12) signaling axis represents a crucial drug target due to its relevance to several diseases such as HIV-1 infection, cancer, leukemia, and rheumatoid arthritis. With the aim of enhancing the binding affinity and anti-HIV activity of a potent CXCR4 ligand as a lead, 23 low molecular weight compounds containing dipicolylamine (Dpa) and cyclam cationic moieties with varying spacers and spatial positioning were designed, synthesized and biologically evaluated. All of the synthesized compounds screened at 1.0 μM in the NanoBRET assay system exhibited >70% inhibition of the binding of a competitive probe TAMRA-Ac-TZ14011 (10 nM) to CXCR4 in the presence of zinc (II) ion. Furthermore, selected compounds 3, 8, 9, 19 and 21 with spatial distances between the next carbon to Dpa and the next carbon to cyclam within the range of 6.5–7.5 ? showed potent binding affinity selective for CXCR4 with IC50 values of 1.6, 7.9, 5.7, 3.5 and 4.5 nM, respectively, with corresponding high anti-HIV activity with EC50s of 28, 13, 21, 28 and 61 nM, respectively, in the presence of zinc (II) ion. Some compounds with remarkably more potent CXCR4-binding affinity than that of an initial lead were obtained. These compounds interact with different but overlapping amino acid residues of CXCR4. The present studies have developed new low molecular weight CXCR4 ligands with high CXCR4-binding and anti-HIV activities, which open avenue into the development of more potent CXCR4 ligands.

Halogenation through Deoxygenation of Alcohols and Aldehydes

Chen, Jia,Lin, Jin-Hong,Xiao, Ji-Chang

supporting information, p. 3061 - 3064 (2018/05/28)

An efficient reagent system, Ph3P/XCH2CH2X (X = Cl, Br, or I), was very effective for the deoxygenative halogenation (including fluorination) of alcohols (including tertiary alcohols) and aldehydes. The easily available 1,2-dihaloethanes were used as key reagents and halogen sources. The use of (EtO)3P instead of Ph3P could also realize deoxy-halogenation, allowing for a convenient purification process, as the byproduct (EtO)3Pa?O could be removed by aqueous washing. The mild reaction conditions, wide substrate scope, and wide availability of 1,2-dihaloethanes make this protocol attractive for the synthesis of halogenated compounds.

Silver-Catalyzed Decarboxylative Bromination of Aliphatic Carboxylic Acids

Tan, Xinqiang,Song, Tao,Wang, Zhentao,Chen, He,Cui, Lei,Li, Chaozhong

supporting information, p. 1634 - 1637 (2017/04/11)

The silver-catalyzed Hunsdiecker bromination of aliphatic carboxylic acids is described. With Ag(Phen)2OTf as the catalyst and dibromoisocyanuric acid as the brominating agent, various aliphatic carboxylic acids underwent decarboxylative bromination to provide the corresponding alkyl bromides under mild conditions. This method not only is efficient and general but also enjoys wide functional group compatibility. An oxidative radical mechanism involving Ag(II) intermediates is proposed.

Generation of α-imino gold carbenes through gold-catalyzed intermolecular reaction of azides with ynamides

Shu, Chao,Wang, Yong-Heng,Zhou, Bo,Li, Xin-Ling,Ping, Yi-Fan,Lu, Xin,Ye, Long-Wu

supporting information, p. 9567 - 9570 (2015/08/18)

The generation of α-imino gold carbenes via gold-catalyzed intermolecular reaction of azides and ynamides is disclosed. This new methodology allows for highly regioselective access to valuable 2-aminoindoles and 3-amino-β-carbolines in generally good to excellent yields. A mechanistic rationale for this tandem reaction, especially for the observed high regioselectivity, is supported by DFT calculations.

A scalable procedure for light-induced benzylic brominations in continuous flow

Cantillo, David,De Frutos, Oscar,Rincon, Juan A.,Mateos, Carlos,Oliver Kappe

supporting information, p. 223 - 229 (2014/01/17)

A continuous-flow protocol for the bromination of benzylic compounds with N-bromosuccinimide (NBS) is presented. The radical reactions were activated with a readily available household compact fluorescent lamp (CFL) using a simple flow reactor design based on transparent fluorinated ethylene polymer (FEP) tubing. All of the reactions were carried out using acetonitrile as the solvent, thus avoiding hazardous chlorinated solvents such as CCl4. For each substrate, only 1.05 equiv of NBS was necessary to fully transform the benzylic starting material into the corresponding bromide. The general character of the procedure was demonstrated by brominating a diverse set of 19 substrates containing different functional groups. Good to excellent isolated yields were obtained in all cases. The novel flow protocol can be readily scaled to multigram quantities by operating the reactor for longer time periods (throughput 30 mmol h-1), which is not easily possible in batch photochemical reactors. The bromination protocol can also be performed with equal efficiency in a larger flow reactor utilizing a more powerful lamp. For the bromination of phenylacetone as a model, a productivity of 180 mmol h -1 for the desired bromide was achieved.

One-pot transformation of methylarenes into aromatic aldehydes under metal-free conditions

Tabata, Masayuki,Moriyama, Katsuhiko,Togo, Hideo

, p. 3402 - 3410 (2014/06/09)

On the basis of studies of the transformation of benzylic bromides into the corresponding aromatic aldehydes by treatment with N-methylmorpholine N-oxide, various methylarenes were treated either with DBDMH in the presence of AIBN in acetonitrile at reflux (Method A) or with NBS in CCl4 under irradiation with a tungsten lamp at 30 °C (Method B), followed by treatment with N-methylmorpholine N-oxide to provide aromatic aldehydes in good yields. These methods could be adopted in one-pot transformations of methylarenes into aromatic aldehydes under conditions free of less toxic reagents and transition metals. Copyright

Antitrypanosomal lead discovery: Identification of a ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growth

Andriani, Grasiella,Amata, Emanuele,Beatty, Joel,Clements, Zeke,Coffey, Brian J.,Courtemanche, Gilles,Devine, William,Erath, Jessey,Juda, Cristin E.,Wawrzak, Zdzislaw,Wood, Jodianne T.,Lepesheva, Galina I.,Rodriguez, Ana,Pollastri, Michael P.

, p. 2556 - 2567 (2013/05/09)

Chagas disease is caused by the intracellular protozoan parasite Trypanosomal cruzi, and current drugs are lacking in terms of desired safety and efficacy profiles. Following on a recently reported high-throughput screening campaign, we have explored initial structure-activity relationships around a class of imidazole-based compounds. This profiling has uncovered compounds 4c (NEU321) and 4j (NEU704), which are potent against in vitro cultures of T. cruzi and are greater than 160-fold selective over host cells. We report in vitro drug metabolism and properties profiling of 4c and show that this chemotype inhibits the T. cruzi CYP51 enzyme, an observation confirmed by X-ray crystallographic analysis. We compare the binding orientation of 4c to that of other, previously reported inhibitors. We show that 4c displays a significantly better ligand efficiency and a shorter synthetic route over previously disclosed CYP51 inhibitors, and should therefore be considered a promising lead compound for further optimization.

Direct oxidative conversion of methylarenes into aromatic nitriles

Tsuchiya, Daisuke,Kawagoe, Yuhsuke,Moriyama, Katsuhiko,Togo, Hideo

supporting information, p. 4194 - 4197 (2013/09/12)

A variety of methylarenes were successfully converted into the corresponding aromatic nitriles in good to moderate yields by the treatment with NBS or DBDMH in the presence of a catalytic amount of AIBN or BPO, followed by the reaction with molecular iodine in aq NH3 in a one-pot procedure. The present reaction is a useful and practical transition-metal-free method for the preparation of aromatic nitriles from methylarenes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 823-78-9